The Microsetta Initiative studies human microbiomes, analyzing diverse data to reveal links between microbes, diet, and health for improved public health.
Three big winners from AbbVie’s $8.7B Cerevel deal: A drugmaker, a CEO and a SPAC
AbbVie’s $8.7 billion deal for Cerevel comes with some interesting subplots. The acquisition of course sets up AbbVie for life after Humira, but it also